Generation Bio Co (NAS:GBIO)
$ 2.64 -0.13 (-4.69%) Market Cap: 176.20 Mil Enterprise Value: 53.21 Mil PE Ratio: 0 PB Ratio: 1.61 GF Score: 34/100

Generation Bio Co at Canaccord Genuity Growth Conference Transcript

Aug 10, 2023 / 03:00PM GMT
Release Date Price: $4.35 (+1.16%)
Joohwan Kim
Canaccord Genuity Group Inc. - Analyst

Welcome and thanks for attending Canaccord Genuity's 43rd Annual Growth Conference. My name is Joohwan Kim and I am an associate on Whitney Ijem's genetic medicine and rare disease team. And we're very excited to have the team from Generation Bio here. It's my great pleasure to introduce the CFO, Matt Norkunas. And Generation Bio is a biotechnology company, innovating genetic medicines for people living with rare and prevalent diseases. And so with that, I'll turn it over to the team for their presentation.

Matt Norkunas
Generation Bio Co. - CFO

Thank you. Can everybody hear me? Oh, yeah, for sure. The microphone is working. So hi, everybody. Thanks for coming. I'm Matt Norkunas. I'm here to tell you the story of Gen Bio today.

Before I dive into the slides, just a little background, we were founded six years ago. And our goal is to bring to the world non-viral DNA genetic medicines. It's a very difficult challenge. It's an idea that's been around for a long time and very little progress has been

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot